News

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.
GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to ...
“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...
Participants on the 36 mg oral dose drop 12.4% of their body weight at 72 weeks, yet physicians warn of posttreatment weight ...
Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.
The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic ...
Semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes, according to new research. Semaglutide is ...